Filing Details

Accession Number:
0001140361-15-024853
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-18 21:27:03
Reporting Period:
2015-06-16
Filing Date:
2015-06-18
Accepted Time:
2015-06-18 21:27:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1059790 Pozen Inc POZN Pharmaceutical Preparations (2834) 621657552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478570 G. John Fort C/o Pozen Inc.
1414 Raleigh Road, Suite 400
Chapel Hill NC 27517
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-16 10,179 $1.98 57,975 No 4 M Direct
Common Stock Disposition 2015-06-16 10,179 $10.00 47,796 No 4 S Direct
Common Stock Acquisiton 2015-06-16 5,497 $8.36 53,293 No 4 M Direct
Common Stock Disposition 2015-06-16 4,945 $10.02 48,348 No 4 F Direct
Common Stock Acquisiton 2015-06-17 18,322 $4.64 66,670 No 4 M Direct
Common Stock Disposition 2015-06-17 18,322 $10.68 48,348 No 4 S Direct
Common Stock Acquisiton 2015-06-17 2,386 $3.77 50,734 No 4 M Direct
Common Stock Disposition 2015-06-17 2,386 $10.78 48,348 No 4 S Direct
Common Stock Acquisiton 2015-06-18 11,373 $3.77 59,721 No 4 M Direct
Common Stock Disposition 2015-06-18 11,373 $10.78 48,348 No 4 S Direct
Common Stock Acquisiton 2015-06-18 36,645 $5.33 84,993 No 4 M Direct
Common Stock Disposition 2015-06-18 36,645 $11.37 48,348 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-06-16 10,179 $0.00 15,268 $1.98
Common Stock Stock Option (right to buy) Disposition 2015-06-16 5,497 $0.00 7,329 $8.36
Common Stock Stock Option (right to buy) Disposition 2015-06-17 18,322 $0.00 18,322 $4.64
Common Stock Stock Option (right to buy) Disposition 2015-06-17 2,386 $0.00 13,759 $3.77
Common Stock Stock Option (right to buy) Disposition 2015-06-18 11,373 $0.00 11,373 $3.77
Common Stock Stock Option (right to buy) Disposition 2015-06-18 36,645 $0.00 36,645 $5.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,089 2021-01-03 No 4 M Direct
1,832 2018-03-15 No 4 M Direct
0 2019-03-13 No 4 M Direct
11,373 2021-03-15 No 4 M Direct
0 2021-03-15 No 4 M Direct
0 2020-03-15 No 4 M Direct
Footnotes
  1. Stock option exercise and open market sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $9.93 to $10.09.
  3. Represents shares of the Registrant's common stock delivered as payment of exercise price and applicable taxes in connection with the net exercise of stock options by the reporting person. Such shares are to be delivered to the Registrant's treasury account.
  4. Reflects the closing price of the Registrant's common stock as reported by the NASDAQ Stock Market on June 16, 2015.
  5. The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $10.66 to $10.74.
  6. The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $10.78 to 10.79.
  7. Exercisable upon achievement of certain performance criteria.
  8. The option vests 25% annually over four years commencing upon the first anniversary of the date of grant.
  9. The reporting person has provided to the Registrant, and the Registrant will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.